VA HB312 | 2020 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on December 31 2019 - 25% progression, died in chamber
Action: 2020-01-28 - Stricken from docket by Health, Welfare and Institutions (22-Y 0-N)
Text: Latest bill text (Prefiled) [HTML]
Status: Introduced on December 31 2019 - 25% progression, died in chamber
Action: 2020-01-28 - Stricken from docket by Health, Welfare and Institutions (22-Y 0-N)
Text: Latest bill text (Prefiled) [HTML]
Summary
Board of Pharmacy; information about naloxone. Directs the Board of Pharmacy to include in each annual license renewal communication information about the dispensing, possession, and administration of naloxone or other opioid antagonist, including information about laws governing the dispensing, possession, and administration of naloxone or other opioid antagonist and civil immunity for individuals who administer naloxone or other opioid antagonist to a person believed to be experiencing an opioid overdose.
Title
Naloxone or other opioid antagonist; communication of information by Board of Pharmacy.
Sponsors
Roll Calls
2020-01-28 - House - House: Stricken from docket by Health, Welfare and Institutions (22-Y 0-N) (Y: 22 N: 0 NV: 0 Abs: 0) [PASS]
History
Date | Chamber | Action |
---|---|---|
2020-01-28 | House | Stricken from docket by Health, Welfare and Institutions (22-Y 0-N) |
2019-12-31 | House | Referred to Committee on Health, Welfare and Institutions |
2019-12-31 | House | Prefiled and ordered printed; offered 01/08/20 20101561D |